Literature DB >> 10792635

Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis.

M M Ward1.   

Abstract

BACKGROUND: Although the outcomes of renal transplantation among patients with end-stage renal disease (ESRD) caused by lupus nephritis have generally been found to be comparable to those of patients with other causes of ESRD, some studies indicate that cadaveric graft failure is more common among these patients. However, most previous studies examined small numbers of patients and did not adjust for important confounding factors.
METHODS: Graft failure and patient mortality after the first cadaveric renal transplantation were compared between 772 adults with ESRD caused by lupus nephritis and 32,644 adults with ESRD caused by other causes who received a transplant between 1987 and 1994 and were included in the United States Renal Data System. The median follow-up times were 4.9 and 5.0 years in the two groups, respectively. Multivariate Cox regression models were used to adjust the risks of graft failure and mortality for group differences in recipient and donor characteristics. Similar comparisons were performed between 390 adults with ESRD caused by lupus nephritis and 10,512 adults with ESRD caused by other causes after first living-related renal transplantation.
RESULTS: In an unadjusted analysis, the risk of graft failure after first cadaveric transplant was slightly but significantly greater among patients with ESRD caused by lupus nephritis than among those with ESRD caused by other causes [hazard ratio (HR), 1.13; 95% CI, 1.01 to 1. 26, P = 0.04]. However, after adjustment for potential confounding factors, the risk of graft failure was not increased in patients with ESRD caused by lupus nephritis (HR, 1.08; 95% CI, 0.94 to 1.23, P = 0.28). Mortality after the first cadaveric transplantation did not differ between groups. The adjusted risks of graft failure (HR, 1.06; 95% CI, 0.84 to 1.32, P = 0.62) and patient mortality (HR = 0. 69; 95% CI, 0.45 to 1.05, P = 0.09) after the first living-related renal transplant were also not significantly higher among patients with ESRD caused by lupus nephritis.
CONCLUSIONS: Graft and patient survival after first cadaveric and first living-related renal transplants are similar in patients with ESRD caused by lupus nephritis and patients with ESRD from other causes.

Entities:  

Mesh:

Year:  2000        PMID: 10792635     DOI: 10.1046/j.1523-1755.2000.00065.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Kidney Transplantation Outcomes across GN Subtypes in the United States.

Authors:  Michelle M O'Shaughnessy; Sai Liu; Maria E Montez-Rath; Colin R Lenihan; Richard A Lafayette; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality.

Authors:  Anna Broder; Saakshi Khattri; Ruchika Patel; Chaim Putterman
Journal:  J Rheumatol       Date:  2011-09-01       Impact factor: 4.666

3.  Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.

Authors:  Laura C Plantinga; Rachel E Patzer; Cristina Drenkard; Michael R Kramer; Mitchel Klein; S Sam Lim; William M McClellan; Stephen O Pastan
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-04       Impact factor: 4.794

4.  Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS.

Authors:  Anna Broder; Wenzhu B Mowrey; Ladan Golestaneh; Chaim Putterman; Karen H Costenbader; Mimi Kim
Journal:  Semin Arthritis Rheum       Date:  2018-06-12       Impact factor: 5.532

5.  End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Authors:  Linda T Hiraki; Bing Lu; Steven R Alexander; Tamara Shaykevich; Graciela S Alarcón; Daniel H Solomon; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2011-07

Review 6.  Rituximab therapy in lupus nephritis: current clinical evidence.

Authors:  Manuel Ramos-Casals; Candido Diaz-Lagares; Maria-Jose Soto-Cardenas; Pilar Brito-Zeron; María-José Cuadrado; Giovanni Sanna; Laura Bertolaccini; Munther A Khamashta
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

Review 7.  Reviewing the recommendations for lupus in children.

Authors:  Zehra Serap Arıcı; Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

8.  Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy.

Authors:  John Fredy Nieto-Ríos; Lina María Serna-Higuita; Sheila Alexandra Builes-Rodriguez; Ricardo Cesar Restrepo-Correa; Arbey Aristizabal-Alzate; Catalina Ocampo-Kohn; Angélica Serna-Campuzano; Natalia Cardona-Díaz; Nelson Darío Giraldo-Ramirez; Gustavo Adolfo Zuluaga-Valencia
Journal:  Colomb Med (Cali)       Date:  2016-03-30

9.  Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis.

Authors:  Seok-Hui Kang; Byung-Ha Chung; Sun-Ryoung Choi; Ja-Young Lee; Hoon-Suk Park; In-O Sun; Bum-Soon Choi; Cheol-Whee Park; Yong-Soo Kim; Chul-Woo Yang
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 3.165

10.  Renal transplantation in systemic lupus erythematosus: outcome and prognostic factors in 50 cases from a single centre.

Authors:  Ernesto Cairoli; Carolina Sanchez-Marcos; Gerard Espinosa; Constanza Glucksmann; Guadalupe Ercilla; Federico Oppenheimer; Ricard Cervera
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.